pISSN 2234-3806eISSN 2234-3814
Table. 2.
Antimicrobial resistance of 411
| Antimicrobial agent | Total (N=411) | ≤5 yr (N=43) | 6–64 yr (N=176) | ≥65 yr (N=192) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | ||
| β-Lactams | Penicillin | 62.8 | 24.1 | 13.1 | 58.1 | 23.3 | 18.6 | 61.9 | 22.7 | 15.3 | 64.6 | 25.5 | 9.9 |
| Amoxicillin/clavulanate | 69.3 | 8.8 | 21.9 | 74.4 | 0 | 25.6 | 68.2 | 10.2 | 21.6 | 69.3 | 9.4 | 21.4 | |
| Cefotaxime | 70.8 | 19.7 | 9.5 | 67.4 | 23.3 | 9.3 | 71.6 | 20.5 | 8.0 | 70.8 | 18.2 | 10.9 | |
| Ceftriaxone | 70.3 | 20.4 | 9.2 | 67.4 | 25.6 | 7.0 | 68.2 | 21.6 | 10.2 | 72.9 | 18.2 | 8.9 | |
| Macrolides | Erythromycin | 18.7 | 1.0 | 80.3 | 7.0 | 0 | 93.0 | 18.8 | 0 | 81.3 | 21.4 | 2.1 | 76.6 |
| Lincosamides | Clindamycin | 33.1 | 0.2 | 66.7 | 30.2 | 0 | 69.8 | 31.3 | 0.6 | 68.2 | 35.4 | 0 | 64.6 |
| Quinolones | Levofloxacin | 95.6 | 0.2 | 4.1 | 100 | 0 | 0 | 96.0 | 0 | 4.0 | 93.8 | 0.5 | 5.2 |
| Tetracyclines | Tetracycline | 22.6 | 1.5 | 75.9 | 14.0 | 0 | 86.0 | 22.2 | 1.7 | 76.1 | 25.0 | 1.6 | 73.4 |
| Folate-pathway inhibitors | Trimethoprim/ sulfamethoxazole | 58.6 | 13.6 | 27.7 | 72.1 | 14.0 | 14.0 | 58.0 | 14.2 | 27.8 | 56.3 | 13.0 | 30.7 |
| Glycopeptides | Vancomycin | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 |
Abbreviations: S, susceptible; I, intermediate; R, resistant.
Ann Lab Med 2023;43:45~54 https://doi.org/10.3343/alm.2023.43.1.45
© Ann Lab Med